Multiplex bead-PCR diagnosis for AIDS diarrhea

多重微珠 PCR 诊断艾滋病腹泻

基本信息

  • 批准号:
    7273893
  • 负责人:
  • 金额:
    $ 18.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-15 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic diarrhea is a curse for AIDS patients through its association with advanced lymphopenia and mortality. Its incidence is greatest in sub-Saharan Africa where it may undermine absorption of HAART. Diagnosis is flawed by the poor sensitivity of available tests for pathogen detection. We hypothesize that diagnostic failure to detect opportunistic infection accounts for a large proportion of AIDS diarrhea cases given "no diagnosis." In this proposal we will develop a sensitive bead-PCR assay that detects multiple pathogens in single reaction and then test our hypothesis on 401 existing stool specimens from our prior AIDS cohort study from Tanzania, whereby 78% of diarrhea cases revealed no pathogen via microscopy or antigen detection. Based on the practicality of an R21 application, our experience with protozoa, and reviewer's comments, we will limit this project to Cryptosporidium, Giardia, Isospora, and the two major intestinal Microsporidia. The assay involves conventional PCR using biotinylated primers followed by hybridization of amplicon to oligonucleotide probes that are covalently linked to uniquely colored beads. Fluorescence is generated by addition of streptavidin-PE and quantitated per bead color on a Luminex suspension array machine, such that up to 100 pathogen species can be simultaneously resolved. Development of the assay is not trivial and requires attention to the initial multiplex PCR and optimization of amplicon-probe signal-to-noise ratio. We have preliminary data that the procedure is sensitive and specific, as well as the necessary reagents (parasite DNA), equipment (Luminex machine), and real-time PCR assays for Giardia and Cryptosporidium that can be used to validate the new procedure. Through generation of preliminary data from this proposal we will plan to transfer the technique to our ongoing clinical site in Tanzania, where it can be used on a research basis to characterize prevailing pathogens in order to devise appropriate management algorithms. Finally, syndrome-based multiplex diagnosis is the platform of the future for clinical microbiology, and if this assay works on stool it should work on sputum, blood, or spinal fluid.
描述(由申请人提供):慢性腹泻与晚期淋巴细胞减少症和死亡率相关,对艾滋病患者来说是一种诅咒。其发病率在撒哈拉以南非洲地区最为严重,可能会破坏高效抗逆转录病毒疗法的吸收。由于现有病原体检测测试的敏感性较差,诊断存在缺陷。我们假设“未诊断”的艾滋病腹泻病例中很大一部分是由于诊断失败而未能发现机会性感染。在本提案中,我们将开发一种灵敏的珠子 PCR 检测方法,可在单次反应中检测多种病原体,然后用来自坦桑尼亚的 401 份现有粪便样本检验我们的假设,其中 78% 的腹泻病例通过显微镜或抗原检测未发现病原体。基于 R21 应用的实用性、我们对原生动物的经验以及审稿人的意见,我们将这个项目限制为隐孢​​子虫、贾第鞭毛虫、等孢子虫和两种主要的肠道微孢子虫。该测定涉及使用生物素化引物的常规 PCR,然后将扩增子与共价连接到独特颜色珠子的寡核苷酸探针杂交。通过添加链霉亲和素-PE 产生荧光,并在 Luminex 悬浮阵列机器上对每个珠子颜色进行定量,从而可以同时解析多达 100 种病原体。该检测方法的开发并非易事,需要关注初始多重 PCR 和扩增子探针信噪比的优化。我们有初步数据表明该程序敏感且特异,以及必要的试剂(寄生虫 DNA)、设备(Luminex 机器)以及贾第鞭毛虫和隐孢子虫的实时 PCR 检测,可用于验证新程序。通过从该提案中生成初步数据,我们将计划将该技术转移到我们在坦桑尼亚正在进行的临床站点,在那里可以在研究基础上使用它来描述流行病原体的特征,以便设计适当的管理算法。最后,基于综合征的多重诊断是临床微生物学未来的平台,如果这种检测方法适用于粪便,那么它也适用于痰液、血液或脊髓液。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC R HOUPT其他文献

ERIC R HOUPT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC R HOUPT', 18)}}的其他基金

Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
弗吉尼亚分枝杆菌肺病:复发和结果的测序和临床决定因素
  • 批准号:
    10543980
  • 财政年份:
    2021
  • 资助金额:
    $ 18.39万
  • 项目类别:
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
弗吉尼亚分枝杆菌肺病:复发和结果的测序和临床决定因素
  • 批准号:
    10321219
  • 财政年份:
    2021
  • 资助金额:
    $ 18.39万
  • 项目类别:
Diagnostics and Pharmacotherapy for Severe Forms of TB
严重结核病的诊断和药物治疗
  • 批准号:
    9127086
  • 财政年份:
    2015
  • 资助金额:
    $ 18.39万
  • 项目类别:
Diagnostics and Pharmacotherapy for Severe Forms of TB
严重结核病的诊断和药物治疗
  • 批准号:
    8819855
  • 财政年份:
    2015
  • 资助金额:
    $ 18.39万
  • 项目类别:
Genotyping and Pharmacokinetics in the HIV/MDR-TB epidemic of Eastern Siberia
东西伯利亚艾滋病毒/耐多药结核病流行的基因分型和药代动力学
  • 批准号:
    8793095
  • 财政年份:
    2014
  • 资助金额:
    $ 18.39万
  • 项目类别:
Genotyping and Pharmacokinetics in the HIV/MDR-TB epidemic of Eastern Siberia
东西伯利亚艾滋病毒/耐多药结核病流行的基因分型和药代动力学
  • 批准号:
    8605359
  • 财政年份:
    2014
  • 资助金额:
    $ 18.39万
  • 项目类别:
Reduced Injectable, Short-course for (E)Xpert MDR-TB [RISE trial]
(E)Xpert 耐多药结核病的短期注射减少 [RISE 试验]
  • 批准号:
    8732395
  • 财政年份:
    2014
  • 资助金额:
    $ 18.39万
  • 项目类别:
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea
用于以患者为导向的传染病现场研究的分子诊断工具
  • 批准号:
    8580369
  • 财政年份:
    2013
  • 资助金额:
    $ 18.39万
  • 项目类别:
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases
用于以患者为导向的传染病现场研究的分子诊断工具
  • 批准号:
    10199920
  • 财政年份:
    2013
  • 资助金额:
    $ 18.39万
  • 项目类别:
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases
用于以患者为导向的传染病现场研究的分子诊断工具
  • 批准号:
    10443710
  • 财政年份:
    2013
  • 资助金额:
    $ 18.39万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 18.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 18.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了